Alzheimer's drug from Biogen, partner gains FDA approval
U.S. health officials approved a closely watched Alzheimer's drug, Leqembi, that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and thei…
U.S. health officials approved a closely watched Alzheimer's drug, Leqembi, that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and thei…